R. Morita

发表

Fracture simulation of the femoral bone using the finite-element method: How a fracture initiates and proceeds

T. Ota, I. Yamamoto, R. Morita, 1999, Journal of Bone and Mineral Metabolism.

Relationship between skeletal uptake of99mTc-HMDP and bone mineral density in elderly women

M. Takada, T. Ota, I. Yamamoto, 1998, Annals of nuclear medicine.

Urinary pyridinoline and deoxypyridinoline as bone metabolic markers in predicting therapeutic effects of estrogen and alfacalcidol in women with osteoporosis

I. Yamamoto, R. Morita, Z. Zhan, 1999, Journal of Bone and Mineral Metabolism.

Three-dimensional bone scintigraphy using volume-rendering technique and SPECT.

K. Murata, T. Suzuki, T. Ota, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group)

Y. Taketani, M. Fukunaga, Y. Ohashi, 2003, Osteoporosis International.

A Comparison of the Effect of Risedronate and Etidronate on Lumbar Bone Mineral Density in Japanese Patients with Osteoporosis: A Randomized Controlled Trial

Y. Taketani, M. Fukunaga, Y. Ohashi, 2002, Osteoporosis International.

Vertebral bone mineral measurement: A comparative study between quantitative computed tomography and dual X-ray absorptiometry

M. Takada, I. Yamamoto, R. Morita, 1994, Journal of Bone and Mineral Metabolism.

Bone fragility induced by x-ray irradiation in relation to cortical bone-mineral content

I. Yamamoto, R. Morita, H. Kimura, 1998, Acta radiologica.

Evaluation of bone scintigraphy in cancer of the head and neck.

R. Morita, Y. Orita, Hidekazu Yamamoto, 1987 .

The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer

T. Tomomitsu, T. Sone, M. Fukunaga, 1985, European Journal of Nuclear Medicine.

The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.

T. Tomomitsu, T. Sone, M. Fukunaga, 1985, European journal of nuclear medicine.

Tumor-induced vitamin D-resistant hypophosphatemic osteomalacia associated with proximal renal tubular dysfunction and 1,25-dihydroxyvitamin D deficiency.

M. Fukunaga, S. Tarui, R. Morita, 1979, The Journal of clinical endocrinology and metabolism.

[Clinical studies using measurement of N-telopeptides of type 1 collagen (NTx) in patients with bone metastasis--comparison with bone scintigraphy and other metabolic bone markers].

I. Yamamoto, R. Morita, T. Sone, 1995, Kaku igaku. The Japanese journal of nuclear medicine.

Indexes of bone mineral content on second metacarpal bone roentgenogram analyzed by digital image processing: a comparison with other bone mass quantifying methods.

T. Tomomitsu, M. Fukunaga, R. Morita, 1990, Radiation medicine.

Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.

T. Tomomitsu, T. Sone, M. Fukunaga, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Normative values of lumbar spine mineral density and fracture threshold in Japanese measured by dual photon absorptiometry based on scinticamera methods (Dualomex HC-1)

M. Fukunaga, J. Konishi, T. Fujita, 1990, Journal of Bone and Mineral Metabolism.

Increased accumulation of N-isopropyl-p-(123I)-iodoamphetamine in two cases with mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS)

M. Fukunaga, R. Morita, T. Yasuda, 2004, Neuroradiology.

Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.

M. Fukunaga, K. Torizuka, I. Yamamoto, 1981, Endocrinology.

Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.

M. Fukunaga, R. Morita, N. Ishikawa, 1976, Endocrinologia japonica.

Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol

K. Kaneda, K. Takaoka, Y. Sugioka, 2007, Journal of Bone and Mineral Metabolism.

Lung scintigraphy with 51Cr-erythrocytes in Goodpasture's syndrome: case report.

K. Hamamoto, K. Torizuka, R. Morita, 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.

K. Torizuka, I. Yamamoto, R. Morita, 1985, The Journal of clinical endocrinology and metabolism.

[Studies on the measurement of vitamin D derivatives in human plasma. I. A competitive protein binding assay for 25-hydroxyvitamin D in plasma (author's transl)].

M. Fukunaga, K. Torizuka, I. Yamamoto, 1981, Nihon Naibunpi Gakkai zasshi.

Chronic intramedullary infusion of interleukin-1α increases bone mineral content in rats

M. Takada, I. Yamamoto, R. Morita, 1994, Calcified Tissue International.

Primary aldosteronism. Photoscanning of tumors after administration of 131 I-19-iodocholesterol.

W. Beierwaltes, R. Morita, W. Mcdonald, 1972, Archives of internal medicine.

Diagnostic validity of bone metabolic markers for bone metastasis.

M. Takada, I. Yamamoto, R. Morita, 1997, Endocrine journal.

[The effects of oral doses of 1, 25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 on intestinal calcium absorption and serum 1, 25-dihydroxyvitamin D level: a study in healthy adults and in postmenopausal osteoporosis].

M. Fukunaga, T. Mukai, K. Torizuka, 1982, Nihon Naibunpi Gakkai zasshi.

Effect of an Intermittent Weekly Dose of Human Parathyroid Hormone (1-34) on Osteoporosis: A Randomized Double-Masked Prospective Study Using Three Dose Levels

M. Fukunaga, H. Orimo, R. Morita, 1999, Osteoporosis International.

Competitive protein binding assay for 1,25-dihydroxy-vitamin D in human plasma.

M. Fukunaga, K. Torizuka, I. Yamamoto, 1978, Endocrinologia japonica.

[Studies on the measurement of vitamin D derivatives in human plasma. II. A fundamental study on the multiple assay for vitamin D derivatives (author's transl)].

M. Fukunaga, K. Torizuka, I. Yamamoto, 1981, Nihon Naibunpi Gakkai zasshi.

Estimation of bone mineral density and bone loss by means of bone metabolic markers in postmenopausal women.

I. Yamamoto, R. Morita, Y. Kigami, 1995, Endocrine journal.

Chronological changes of3H-1,25(OH)2D3 in tissue and serum after consecutive oral doses of active vitamin D in rats : Comparative study of 1αOHD3 and 1,25(OH)2D3

M. Fukunaga, T. Nakano, R. Morita, 1989, Journal of Bone and Mineral Metabolism.

Spontaneous bilateral intracerebral hemorrhage occurring simultaneously--case report.

T. Sone, M. Fukunaga, A. Kohama, 1986, Neurologia medico-chirurgica.

Evidence that factors other than 1,25 dihydroxyvitamin D may play a role in augmenting intestinal calcium absorption in patients with primary hyperparathyroidism

M. Fukunaga, K. Torizuka, I. Yamamoto, 1986, Calcified Tissue International.

Scintigraphic diagnosis of primary and metastatic bone tumour by technetium-99m diphosphonate

K. Hamamoto, K. Torizuka, I. Yamamoto, 1978, International Orthopaedics.

Accumulation of 99mTc-pyrophosphate in a muscle hernia of the thigh

M. Fukunaga, K. Torizuka, I. Yamamoto, 2004, European Journal of Nuclear Medicine.

[Bone mineral determination using dual energy X-ray absorptiometry (DEXA)].

T. Tomomitsu, M. Fukunaga, R. Morita, 1990, Rinsho hoshasen. Clinical radiography.

Percent uptake of 131-I radioactivity in the adrenal from radioiodinated cholesterol.

W. Beierwaltes, R. Morita, H. Nishiyama, 1972, The Journal of clinical endocrinology and metabolism.

99Tcm chemical state in 99Tcm labeled radiopharmaceuticals--I. Preparation and biological behavior of 99Tcm-penicillamine complex with a low hydrolyzed 99Tcm state.

H. Saji, K. Torizuka, A. Yokoyama, 1978, International journal of nuclear medicine and biology.

Bone Scintigraphy in Pulmonary Alveolar Microlithiasis: A Comparative Study of Radioactivity and Density Distribution

K. Torizuka, H. Maeda, R. Morita, 1982, Clinical nuclear medicine.

Clinical evaluation of serum ferritin to iron ratio in malignant diseases

K. Torizuka, R. Morita, Rikushi Morita, 2004, European Journal of Nuclear Medicine.

Accumulation of 99mTc-methylene diphosphonate within benign cystic teratoma of the ovary

M. Fukunaga, T. Fujita, K. Torizuka, 2004, European Journal of Nuclear Medicine.

Visualization of Soft Tissue by Technetium‐99m MDP in Polymyositis Case Reports

T. Tomomitsu, R. Morita, A. Terao, 1988, Clinical nuclear medicine.

Visualization of skeletal muscle involvement of mycosis fungoides on 67Ga scintigraphy

M. Fukunaga, K. Torizuka, R. Morita, 1982, European Journal of Nuclear Medicine.

Hemorrhagic infarction of the diseased ovary: a common MR finding in two cases.

K. Murata, A. Furukawa, R. Morita, 1993, Magnetic resonance imaging.

Accumulation of 201TI-Chloride in a Parathyroid Adenoma

Y. Yonekura, T. Fujita, K. Torizuka, 1979, Clinical nuclear medicine.

Usefulness of Bone Imaging in Diagnosis of Sternocostoclavicular Hyperostosis

T. Tomomitsu, T. Sone, R. Morita, 1986, Radioisotopes.

Usefulness of bone imaging in diagnosis of sternocostoclavicular hyperostosis.

T. Tomomitsu, T. Sone, M. Fukunaga, 1989, Clinical nuclear medicine.

Circulating 1,25-dihydroxyvitamin D concentrations in patients with renal cell carcinoma-associated hypercalcemia are rarely suppressed.

K. Torizuka, J. Kawamura, I. Yamamoto, 1987, The Journal of clinical endocrinology and metabolism.

Accumulation of 99mTc-methylene diphosphonate in a so-called conversion defect of the femoral neck

M. Fukunaga, K. Torizuka, R. Morita, 2004, European Journal of Nuclear Medicine.

A Case of Synovial Sarcoma with Bone Metastasis Identified by Bone Marrow Scintigraphy

T. Tomomitsu, T. Sone, R. Morita, 1984, Kaku igaku. The Japanese journal of nuclear medicine.

Visualization of aldosterone-producing tumors (APT) by scintillation scanning (SS) employing tracer amounts of 131 -iodocholesterol.

C. Lucas, W. Beierwaltes, R. Morita, 1971, The Journal of laboratory and clinical medicine.

Histological Findings of Paget's Disease of Bone

M. Fukunaga, K. Torizuka, I. Yamamoto, 1986 .

Preparation of a chemically characterized 99mTc-penicillamine complex.

H. Saji, A. Yokoyama, R. Morita, 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intrapancreatic accessory spleen diagnosed by technetium-99m heat-damaged red blood cell SPECT.

M. Tei, T. Ota, I. Yamamoto, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technetium coordination state as a factor of stability in 99mTc-complexes used in hepatobiliary system: Comparative studies on 99mTc-complexes of pyridoxal with glutamate (Tc-PG) and isoleucine (Tc-PI)

H. Saji, K. Torizuka, A. Yokoyama, 1981, European Journal of Nuclear Medicine.

Analysis of 99mTc-pyridoxylidene-glutamate complex formation and its preparation with tin-adsorbed-resin: Sn-resin kit method

H. Saji, K. Torizuka, A. Yokoyama, 1981, European Journal of Nuclear Medicine.

Tin-absorbed resin for the preparation of 99mTc-radiopharmaceuticals: stable complex of 99mTc-bleomycin.

Y. Fujibayashi, K. Torizuka, A. Yokoyama, 1981, The International journal of applied radiation and isotopes.

The importance of the chemical state of 99mTc radiopharmaceuticals: an effective tumor imaging form of 99mTc bleomycin.

K. Torizuka, A. Yokoyama, R. Morita, 1978, The International journal of applied radiation and isotopes.

Studies on liver function test with I 131 BSP monoiodide and scinticamera.

K. Hamamoto, T. Mukai, K. Torizuka, 1971, The American journal of roentgenology, radium therapy, and nuclear medicine.

Chronic intramedullary infusion of prostaglandin E2 stimulates bone formation both in the bone marrow and in the periosteum.

M. Takada, I. Yamamoto, R. Morita, 1995, Endocrine journal.

T. Ota, I. Yamamoto, R. Morita, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Moyamoya-like diseases associated with ventricular hemorrhages: report of three cases.

M. Fukunaga, A. Kohama, R. Morita, 1985, Neurosurgery.

Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application.

M. Fukunaga, K. Torizuka, I. Yamamoto, 1975, Endocrinologia japonica.

[Studies on the measurement of vitamin D derivatives in human plasma. III. Plasma concentrations of vitamin D derivatives in various diseases (author's transl)].

M. Fukunaga, K. Torizuka, I. Yamamoto, 1982, Nihon Naibunpi Gakkai zasshi.

Lateral scanning of the lumbar spine: Bone mineral density determination with dual energy X-ray absorptiometry

T. Tomomitsu, M. Fukunaga, R. Morita, 1991, Journal of Bone and Mineral Metabolism.

Comparison of various biochemical measurements with bone mineral densitometry and quantitative ultrasound for the assessment of vertebral fracture

M. Takada, I. Yamamoto, R. Morita, 2000, Journal of Bone and Mineral Metabolism.

Comparison of bone mineral density at various skeletal sites with quantitative ultrasound parameters of the calcaneus for assessment of vertebral fractures

M. Takada, T. Ota, I. Yamamoto, 1999, Journal of Bone and Mineral Metabolism.

Changes in sex hormones and calcium regulating hormones with reference to bone mass associated with aging.

M. Fukunaga, K. Torizuka, T. Aso, 1979, Endocrinologia Japonica.

Case report: focal fatty infiltration of the liver with accumulation defect on Tc-99m colloid and Tc-99m-GSA scintigraphy.

T. Ota, R. Morita, M. Seki, 1997, Clinical radiology.

[Fifteen cases of Paget's disease of bone--roentgenographic, scintigraphic and histological findings].

M. Fukunaga, R. Morita, S. Shimbo, 1985, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

Fractures in patients with myopathies.

K. Torizuka, I. Yamamoto, R. Morita, 1979, Archives of Physical Medicine and Rehabilitation.

Quantitative ultrasound for the assessment of bone status

M. Takada, I. Yamamoto, R. Morita, 2010, Osteoporosis International.

OPTIMUM ORDER HARMONICS OF FOURIER-ANALYSIS IN MULTIGATED BLOOD-POOL STUDIES

Y. Yonekura, Y. Ishii, N. Tamaki, 1983 .

Visualization of central stellate fibrosis in hyaline vascular type Castleman's disease.

T. Ota, R. Morita, M. Zaima, 1997, The British journal of radiology.

Two optimal prefilter cutoff frequencies needed for SPECT images of myocardial perfusion in a one-day protocol.

R Morita, I Yamamoto, M. Takada, 1997, Journal of nuclear medicine technology.

Photoscanning of Tumors in Primary Aldosteronism: Possible Distinction from “Idiopathic” Aldosteronism

W. Beierwaltes, R. Morita, W. Mcdonald, 1972 .

Aging and Calcium Metabolism

K. Torizuka, R. Morita, 1977 .

Some problems of dual-energy x-ray absorptiometry in the clinical use

K. Kaneda, M. Fukunaga, H. Orimo, 2005, Osteoporosis International.

Clinical value on measurement of squamous cell carcinoma related antigen (scc antigen) in oral cancer

M. Fukunaga, N. Segami, R. Morita, 1987 .

Early changes in bone mineral content caused by acute irradiation are not observed after daily fractionation: A study by dual-energy X-ray absorptiometry

I. Yamamoto, R. Morita, H. Kimura, 2006, Journal of Bone and Mineral Metabolism.

[Recent development and clinical application of bone mineral measurements].

M. Takada, I. Yamamoto, R. Morita, 1998, Nihon rinsho. Japanese journal of clinical medicine.

Co-purification of bone resorbing activity and adenylate cyclase stimulating activity from human tumours associated with the humoral hypercalcaemia of malignancy.

K. Torizuka, I. Yamamoto, R. Morita, 1987, Acta endocrinologica.

Scintigraphic visualization of extraosseous xanthomatosis

M. Fukunaga, K. Torizuka, R. Morita, 2004, European Journal of Nuclear Medicine.